Evidence map›Paper›PMID 42615010›Full record

ArticleBioinformatics advances2026

lncAPNet enables the deciphering of lncRNA-mRNA connections in patient transcriptomic data.

Vasileios Vasileiou, George I Gavriilidis, Pedro Faria Zeni, Marek Mraz, Evangelos Karatzas, Antonis Giakountis, Georgios A Pavlopoulos, Antonis Giannakakis, Fotis Psomopoulos

Abstract read
In one paragraph

Article in Bioinformatics advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Vasileios VasileiouInstitute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, 57001, Greece.ORCID https://orcid.org/0000-0003-0145-033X
George I GavriilidisInstitute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, 57001, Greece.ORCID https://orcid.org/0000-0003-2575-4354
Pedro Faria ZeniMolecular Medicine, Central European Institute of Technology, Masaryk University, Brno, 625 00, Czech Republic.
Marek MrazMolecular Medicine, Central European Institute of Technology, Masaryk University, Brno, 625 00, Czech Republic.
Evangelos KaratzasEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Cambridge, CB10 1SD, UK.
Antonis GiakountisDepartment of Biochemistry and Biotechnology, University of Thessaly, Larissa, 41500, Greece.
Georgios A PavlopoulosInstitute for Fundamental Biomedical Research, BSRC "Alexander Fleming", Vari, 16672, Greece.ORCID https://orcid.org/0000-0002-4577-8276
Antonis GiannakakisDepartment of Molecular Biology and Genetics, Democritus University of Thrace, Alexandroupolis, 68100, Greece.ORCID https://orcid.org/0000-0003-2975-0326
Fotis PsomopoulosInstitute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, 57001, Greece.ORCID https://orcid.org/0000-0002-0222-4273

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Motivation: Long non-coding RNAs regulate gene expression through chromatin remodeling, transcriptional control, and post-transcriptional modulation, influencing physiological cell homeostasis but also disease onset. Yet most transcriptomic and network-based studies rely on descriptive linear co-expression analyses, missing nonlinear and mechanistic insights. Emerging ML/DL methods offer promise but remain limited by data sparsity, noise, insufficient biological priors, and poor interpretability, constraining systems-level lncRNA-mRNA motif discovery. Results: In this manuscript, we introduce lncAPNet, an extended version of the APNet workflow, which integrates graph-based nonlinear inference of lncRNA-mRNA interactions using NetBID2's and scMINERs activity logic within a lncRNA-focused SJARACNe co-expression network, coupled with PASNet, a biologically informed sparse deep learning model. This framework enables explainable identification of lncRNA drivers in three different cancer type case studies, two with bulk RNA-seq datasets [Chronic Lymphocytic Leukemia and Prostate Adenocarcinoma] and one by combining bulk RNA-seq and scRNA-seq omics datasets [Breast Invasive Carcinoma], uncovering lncRNA drivers that illuminate lncRNA-mediated programs in cancer progression. Availability and implementation: lncAPNet's R scripts, Python scripts, and Nextflow pipeline are available at the GitHub repository: https://github.com/BiodataAnalysisGroup/lncAPNet.

Identifiers

PMID42615010
PMCPMC13485353

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.